# Filing Detail

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0000912282-08-000801
Filing Date
2008-05-23
Accepted
2008-05-23 17:06:01
Documents
48
Period of Report
2007-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | oncolytics20f_12312007.htm | 20-F | 2195352
2 | GRAPHIC | ballot.jpg | GRAPHIC | 751
3 | GRAPHIC | ballotx.jpg | GRAPHIC | 762
4 | GRAPHIC | img1.jpg | GRAPHIC | 2342
5 | GRAPHIC | img2.jpg | GRAPHIC | 2342
6 | GRAPHIC | reovirus.jpg | GRAPHIC | 16223
7 | GILL SVC AGMT | ex4_1.htm | EX-4.1 | 3893
8 | GRAPHIC | onsa_p01.jpg | GRAPHIC | 70168
9 | GRAPHIC | onsa_p02.jpg | GRAPHIC | 74740
10 | GRAPHIC | onsa_p03.jpg | GRAPHIC | 96698
11 | GRAPHIC | onsa_p04.jpg | GRAPHIC | 104902
12 | GRAPHIC | onsa_p05.jpg | GRAPHIC | 92137
13 | GRAPHIC | onsa_p06.jpg | GRAPHIC | 91552
14 | GRAPHIC | onsa_p07.jpg | GRAPHIC | 95078
15 | GRAPHIC | onsa_p08.jpg | GRAPHIC | 87966
16 | GRAPHIC | onsa_p09.jpg | GRAPHIC | 53726
17 | GRAPHIC | onsa_p10.jpg | GRAPHIC | 27185
18 | GRAPHIC | onsa_p11.jpg | GRAPHIC | 79665
19 | GRAPHIC | onsa_p12.jpg | GRAPHIC | 60929
20 | GILL AMD AGR NO. 1 | ex4_2.htm | EX-4.2 | 14391
21 | DILLAHUNTY EMP AGR | ex4_3.htm | EX-4.3 | 3133
22 | GRAPHIC | onmad_p01.jpg | GRAPHIC | 85410
23 | GRAPHIC | onmad_p02.jpg | GRAPHIC | 107254
24 | GRAPHIC | onmad_p03.jpg | GRAPHIC | 96820
25 | GRAPHIC | onmad_p04.jpg | GRAPHIC | 130929
26 | GRAPHIC | onmad_p05.jpg | GRAPHIC | 124349
27 | GRAPHIC | onmad_p06.jpg | GRAPHIC | 129072
28 | GRAPHIC | onmad_p07.jpg | GRAPHIC | 129966
29 | GRAPHIC | onmad_p08.jpg | GRAPHIC | 125271
30 | GRAPHIC | onmad_p09.jpg | GRAPHIC | 104929
31 | GRAPHIC | onmad_p10.jpg | GRAPHIC | 128341
32 | GRAPHIC | onmad_p11.jpg | GRAPHIC | 87514
33 | GRAPHIC | onmad_p12.jpg | GRAPHIC | 46696
34 | COFFEY EMP AGR | ex4_4.htm | EX-4.4 | 107135
35 | METTINGER EMP AGR | ex4_5.htm | EX-4.5 | 113124
36 | BALL EMP AGR | ex4_6.htm | EX-4.6 | 106669
37 | THOMPSON EMP AGR | ex4_7.htm | EX-4.7 | 116072
38 | DILLAHUNTY AMD AGR NO. 1 | ex4_8.htm | EX-4.8 | 17969
39 | BALL AMD NO. 1 | ex4_9.htm | EX-4.9 | 13508
40 | COFFEY AMD NO. 1 | ex4_10.htm | EX-4.10 | 13890
41 | THOMPSON AMD NO. 1 | ex4_11.htm | EX-4.11 | 11501
42 | DILLAHUNTY AMD NO. 1 | ex4_12.htm | EX-4.12 | 15697
43 | METTINGER AMD NO. 1 | ex4_13.htm | EX-4.13 | 14913
44 | GILL AMD NO. 2 | ex4_14.htm | EX-4.14 | 13671
45 | CERTIFICATION OF CEO | ex12_1.htm | EX-12.1 | 11616
46 | CERTIFICATION OF CFO | ex12_2.htm | EX-12.2 | 10616
47 | CERTIFICATION OF CEO | ex13_1.htm | EX-13.1 | 6871
48 | CERTIFICATION OF CFO | ex13_2.htm | EX-13.2 | 6839
| Complete submission text file | 0000912282-08-000801.txt |  | 5907478

Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 000-31062 | Film No.: 08858844
SIC: 2834 Pharmaceutical Preparations